Skip to main content
Figure 1 | BMC Gastroenterology

Figure 1

From: Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate

Figure 1

Disease-free survival for 85 patients with small bowel gastrointestinal stromal tumor (GIST) who underwent curative resection in terms of (A) mitotic count; (B) tumor cellularity; (C) Ki-67 index; and overall survival for 85 patients with small bowel GIST who underwent curative resection in terms of (D) tumor perforation; (E) mitotic count; (F) cellularity.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us